MELISSA PRUITT: Open Payments
NPI 1700658838 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $113 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 12 | $214 |
| Hologic Sales and Service, LLC | 2 | $116 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Astellas Pharma US Inc | 2 | $49 |
| PFIZER INC. | 2 | $41 |
| Organon LLC | 2 | $37 |
| Smith+Nephew, Inc. | 1 | $20 |
Products named: ZURZUVAE, ACESSA PROVU SYSTEM, MYFEMBREE, Veozah, ABRYSVO, NEXPLANON, PICO 7, FETAL FIBRONECTIN ENZYME IMMUNOASSAY.
Industry payments across AZ — which companies pay providers there.
